Logotype for Azelis Group NV

Azelis Group (AZE) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Azelis Group NV

H1 2025 earnings summary

16 Nov, 2025

Executive summary

  • Revenue reached €2.2bn in H1 2025, up 0.6% year-over-year, with 1.2% organic growth and 2.2% from acquisitions, offset by FX headwinds and market volatility.

  • EMEA delivered strong growth, offsetting slowdowns in the U.S. and APAC; business model resilience supported by higher cash flows despite margin compression.

  • Free cash flow grew 10.8% to €151m, with cash conversion improving by over 10 percentage points to 63.8%.

  • Three acquisitions (Solchem, S Amit, ACEF) expanded presence in Spain, India, and Italy, with combined 2024 revenue over €100m.

  • Strategic focus remains on innovation, sustainability, digitalization, and cost savings to drive long-term value.

Financial highlights

  • H1 2025 revenue: €2.2bn (+0.6% year-over-year, +1.2% organic); gross profit €515m, down 2.2%, with margin at 23.9%.

  • Adjusted EBITA/EBITDA margin at 10.9%, with adjusted EBITA down 7.7% to €234m.

  • Net profit for H1 2025 was €85.5m, down 14.6% year-over-year.

  • Free cash flow of €151m, with an 11 percentage point increase in cash conversion ratio to 63.8%.

  • Net financial expense decreased 3.4% to €69.9m; effective tax rate at 29%.

Outlook and guidance

  • Macro uncertainty from tariffs, geopolitical instability, and regional conflicts continues to weigh on demand.

  • Cost-saving program (annualized run-rate €20m) to deliver half of savings in H2 2025; focus on cost control and cash preservation.

  • Asset-light model and disciplined cost/working capital management to support resilience and cash generation.

  • Long-term sector fundamentals remain attractive; M&A to resume once leverage stabilizes.

  • Strong positioning to capitalize on industry shifts, supported by global presence and alignment with demand trends.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more